ACSIS: Reperfusion therapies in patients with STEAMI and renal failure
2
ACSIS: Reperfusion therapies in patients with STEAMI and renal failure Dragu R et al. Am J Cardiol 2006; 97:1142- 1145. Therapy Patients, n (%) Thrombolytic therapy 24 (18.2) Primary PCI 35 (26.5) No reperfusion therapy 73 (55.3)
-
Upload
brynn-miller -
Category
Documents
-
view
19 -
download
3
description
ACSIS: Reperfusion therapies in patients with STEAMI and renal failure. Dragu R et al. Am J Cardiol 2006; 97:1142-1145. 30-day crude mortality by reperfusion strategy. Dragu R et al. Am J Cardiol 2006; 97:1142-1145. - PowerPoint PPT Presentation
Transcript of ACSIS: Reperfusion therapies in patients with STEAMI and renal failure
![Page 1: ACSIS: Reperfusion therapies in patients with STEAMI and renal failure](https://reader036.fdocuments.us/reader036/viewer/2022072016/56813342550346895d9a3730/html5/thumbnails/1.jpg)
ACSIS: Reperfusion therapies in patients with STEAMI and renal failure
Dragu R et al. Am J Cardiol 2006; 97:1142-1145.
Therapy Patients, n (%)
Thrombolytic therapy
24 (18.2)
Primary PCI 35 (26.5)
No reperfusion therapy
73 (55.3)
![Page 2: ACSIS: Reperfusion therapies in patients with STEAMI and renal failure](https://reader036.fdocuments.us/reader036/viewer/2022072016/56813342550346895d9a3730/html5/thumbnails/2.jpg)
30-day crude mortality by reperfusion strategy Outcome Thrombolysis Primary
PCINo treatment
p
Crude mortality rate (%)
8.3 40.0 29.7 0.03
Dragu R et al. Am J Cardiol 2006; 97:1142-1145.